Mark Wener to Hydroxychloroquine
This is a "connection" page, showing publications Mark Wener has written about Hydroxychloroquine.
Connection Strength
0.079
-
Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection : A Randomized Trial. Ann Intern Med. 2021 03; 174(3):344-352.
Score: 0.040
-
Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Jun 03; 21(1):475.
Score: 0.039